JP2020536056A - 遅延放出ゲル化剤組成物を含む医薬組成物 - Google Patents

遅延放出ゲル化剤組成物を含む医薬組成物 Download PDF

Info

Publication number
JP2020536056A
JP2020536056A JP2020517421A JP2020517421A JP2020536056A JP 2020536056 A JP2020536056 A JP 2020536056A JP 2020517421 A JP2020517421 A JP 2020517421A JP 2020517421 A JP2020517421 A JP 2020517421A JP 2020536056 A JP2020536056 A JP 2020536056A
Authority
JP
Japan
Prior art keywords
dosage form
oral dosage
solid oral
less
gelling agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020517421A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020536056A5 (enExample
Inventor
デサイ，ミート
ファン，ヒュー，ハイヨン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Pharma LP
Original Assignee
Purdue Pharma LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Pharma LP filed Critical Purdue Pharma LP
Publication of JP2020536056A publication Critical patent/JP2020536056A/ja
Publication of JP2020536056A5 publication Critical patent/JP2020536056A5/ja
Priority to JP2023176374A priority Critical patent/JP7736755B2/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2020517421A 2017-10-02 2018-10-01 遅延放出ゲル化剤組成物を含む医薬組成物 Pending JP2020536056A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023176374A JP7736755B2 (ja) 2017-10-02 2023-10-12 遅延放出ゲル化剤組成物を含む医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762566989P 2017-10-02 2017-10-02
US62/566,989 2017-10-02
PCT/US2018/053755 WO2019070581A1 (en) 2017-10-02 2018-10-01 PHARMACEUTICAL COMPOSITIONS COMPRISING GELIFYING AGENT COMPOSITIONS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023176374A Division JP7736755B2 (ja) 2017-10-02 2023-10-12 遅延放出ゲル化剤組成物を含む医薬組成物

Publications (2)

Publication Number Publication Date
JP2020536056A true JP2020536056A (ja) 2020-12-10
JP2020536056A5 JP2020536056A5 (enExample) 2021-11-04

Family

ID=65995217

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020517421A Pending JP2020536056A (ja) 2017-10-02 2018-10-01 遅延放出ゲル化剤組成物を含む医薬組成物
JP2023176374A Active JP7736755B2 (ja) 2017-10-02 2023-10-12 遅延放出ゲル化剤組成物を含む医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023176374A Active JP7736755B2 (ja) 2017-10-02 2023-10-12 遅延放出ゲル化剤組成物を含む医薬組成物

Country Status (5)

Country Link
US (1) US20200289424A1 (enExample)
EP (1) EP3691645A4 (enExample)
JP (2) JP2020536056A (enExample)
CA (1) CA3074694A1 (enExample)
WO (1) WO2019070581A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4039252A1 (en) * 2021-02-09 2022-08-10 Sanovel Ilac Sanayi Ve Ticaret A.S. A film coated tablet comprising naltrexone hydrochloride

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013528194A (ja) * 2010-06-07 2013-07-08 エティファルム 転用防止微粒剤および微小錠剤
JP2014530185A (ja) * 2011-09-16 2014-11-17 パーデュー ファーマ エルピー 不正改変抵抗性即時放出性製剤
WO2015120201A1 (en) * 2014-02-05 2015-08-13 Kashiv Pharma, Llc Abuse-resistant drug formulations with built-in overdose protection
JP2016507530A (ja) * 2013-02-05 2016-03-10 パーデュー、ファーマ、リミテッド、パートナーシップＰｕｒｄｕｅ Ｐｈａｒｍａ Ｌ．Ｐ． タンパリング抵抗性医薬製剤
JP2017527629A (ja) * 2014-09-12 2017-09-21 レクロ・ゲインズヴィル・エルエルシー 乱用抵抗性医薬組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
US20090022786A1 (en) * 2007-07-16 2009-01-22 Yung Shin Pharm. Ind. Co., Ltd. Oral pharmaceutical dosage form and manufacturing method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013528194A (ja) * 2010-06-07 2013-07-08 エティファルム 転用防止微粒剤および微小錠剤
JP2014530185A (ja) * 2011-09-16 2014-11-17 パーデュー ファーマ エルピー 不正改変抵抗性即時放出性製剤
JP2016507530A (ja) * 2013-02-05 2016-03-10 パーデュー、ファーマ、リミテッド、パートナーシップＰｕｒｄｕｅ Ｐｈａｒｍａ Ｌ．Ｐ． タンパリング抵抗性医薬製剤
WO2015120201A1 (en) * 2014-02-05 2015-08-13 Kashiv Pharma, Llc Abuse-resistant drug formulations with built-in overdose protection
JP2017527629A (ja) * 2014-09-12 2017-09-21 レクロ・ゲインズヴィル・エルエルシー 乱用抵抗性医薬組成物

Also Published As

Publication number Publication date
CA3074694A1 (en) 2019-04-11
EP3691645A1 (en) 2020-08-12
US20200289424A1 (en) 2020-09-17
JP7736755B2 (ja) 2025-09-09
EP3691645A4 (en) 2021-06-23
JP2024009940A (ja) 2024-01-23
WO2019070581A1 (en) 2019-04-11

Similar Documents

Publication Publication Date Title
US12128042B2 (en) Tamper resistant immediate release formulations
US10517832B2 (en) Tamper resistant pharmaceutical formulations
EP2953618B1 (en) Tamper resistant pharmaceutical formulations
JP6110384B2 (ja) 不正改変抵抗性医薬製剤
JP7736755B2 (ja) 遅延放出ゲル化剤組成物を含む医薬組成物
CA2849355C (en) Tamper resistant pharmaceutical formulations
JP2020536892A (ja) 医薬レジネート組成物、それを作製する方法、およびその使用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210922

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210922

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221101

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230112

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230329

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230613